112 related articles for article (PubMed ID: 35906336)
21. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
22. Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma: a retrospective case-control study.
Zang RY; Li ZT; Zhang ZY; Cai SM
Int J Gynecol Cancer; 2003; 13(4):419-27. PubMed ID: 12911717
[TBL] [Abstract][Full Text] [Related]
23. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
Scarabelli C; Gallo A; Carbone A
Gynecol Oncol; 2001 Dec; 83(3):504-12. PubMed ID: 11733963
[TBL] [Abstract][Full Text] [Related]
24. Secondary cytoreductive surgery in recurrent epithelial ovarian cancer: A prognostic analysis with 103 cases.
Fan XM; Zhang J; Niu SH; Li KX; Song CZ
Int J Surg; 2017 Feb; 38():61-66. PubMed ID: 28027999
[TBL] [Abstract][Full Text] [Related]
25. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.
Jänicke F; Hölscher M; Kuhn W; von Hugo R; Pache L; Siewert JR; Graeff H
Cancer; 1992 Oct; 70(8):2129-36. PubMed ID: 1394042
[TBL] [Abstract][Full Text] [Related]
26. Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.
Minaguchi T; Satoh T; Matsumoto K; Sakurai M; Ochi H; Onuki M; Oki A; Yoshikawa H
Int J Clin Oncol; 2016 Jun; 21(3):573-9. PubMed ID: 26475355
[TBL] [Abstract][Full Text] [Related]
27. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
[TBL] [Abstract][Full Text] [Related]
28. Relapse and survival in early-stage ovarian cancer.
Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
[TBL] [Abstract][Full Text] [Related]
29. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group.
Vincent L; Jankowski C; Ouldamer L; Ballester M; Bendifallah S; Bolze PA; Akladios C; Costaz H; Lavoué V; Canlorbe G; Collinet P; Touboul C; Huchon C; Bricou A; Dridi S; Padéano MM; Bengrine L; Arnould L; Coutant C;
Eur J Surg Oncol; 2020 Sep; 46(9):1689-1696. PubMed ID: 32417154
[TBL] [Abstract][Full Text] [Related]
31. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
Fotopoulou C; Zang R; Gultekin M; Cibula D; Ayhan A; Liu D; Richter R; Braicu I; Mahner S; Harter P; Trillsch F; Kumar S; Peiretti M; Dowdy SC; Maggioni A; Trope C; Sehouli J
Ann Surg Oncol; 2013 Apr; 20(4):1348-54. PubMed ID: 23054114
[TBL] [Abstract][Full Text] [Related]
32. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
Nasioudis D; Heyward QD; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
Int J Gynecol Cancer; 2022 Feb; 32(2):165-171. PubMed ID: 34952848
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
34. Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer.
Cress RD; Chen YS; Morris CR; Petersen M; Leiserowitz GS
Obstet Gynecol; 2015 Sep; 126(3):491-497. PubMed ID: 26244529
[TBL] [Abstract][Full Text] [Related]
35. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
[TBL] [Abstract][Full Text] [Related]
36. [Factors affecting long-term survival of advanced high-grade serous ovarian cancer].
Shen YM; Jin LQ; Tang SS; Wang Y; Lyu WG; Chen ZB; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):393-400. PubMed ID: 34154314
[No Abstract] [Full Text] [Related]
37. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.
Bentivegna E; Fruscio R; Roussin S; Ceppi L; Satoh T; Kajiyama H; Uzan C; Colombo N; Gouy S; Morice P
Fertil Steril; 2015 Nov; 104(5):1319-24. PubMed ID: 26149354
[TBL] [Abstract][Full Text] [Related]
38. A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection.
Angioli R; Capriglione S; Aloisi A; Ricciardi R; Scaletta G; Lopez S; Miranda A; Di Pinto A; Terranova C; Plotti F
Ann Surg Oncol; 2015 Dec; 22(13):4217-23. PubMed ID: 25808099
[TBL] [Abstract][Full Text] [Related]
39. Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402).
Hirakawa T; Minaguchi T; Itani Y; Kasamatsu Y; Murase S; Sakurada S; Nagano H; Takehara K; Tsuruta T; Arakawa A; Kawano K; Tsubamoto H; Ushiwaka T; Mori T; Iwai K; Saito M; Morisawa H; Saito F; Yoshida K; Kaneuchi M; Sato H; Ito K; Nasu K
World J Surg Oncol; 2017 Jul; 15(1):132. PubMed ID: 28716033
[TBL] [Abstract][Full Text] [Related]
40. Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival.
Cohen JG; Tran AQ; Rimel BJ; Cass I; Walsh CS; Karlan BY; Li AJ
Gynecol Oncol; 2014 Mar; 132(3):556-9. PubMed ID: 24423879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]